Tob1 plays a critical role in the activation of encephalitogenic t cells in cns autoimmunity

Journal of Experimental Medicine

Volumn 210, Issue 7, 2013, Pages 1301-1309

  Schulze Topphof, Ulf ^a   Casazza, Simona ^a   Varrin Doyer, Michel ^a   Pekarek, Kara ^a   Sobe, Raymond A ^a,b   Hauser, Stephen L ^a   Oksenberg, Jorge R ^a   Zamvil, Scott S ^a   Baranzini, Sergio E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE; LYMPHOCYTE COUNT; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TOB1 GENE;

ANIMALS; CARRIER PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS;

EID: 84880656620     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121611     Document Type: Article

References (30)

1. Bettelli, E., M. Pagany H.L. Weiner, C. Linington, R.A. Sobel, and VK. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specifc T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197:1073-1081. http://dx.doi.org/10.1084/jem.20021603
2. Brex, P.A., O. Ciccarelli, J.I. O'Riordan, M. Sailer, A.J. Thompson, and D.H. Miller. 2002. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N. Engl. J. Med. 346:158-164. http://dx.doi.org/10.1056/NEJMoa011341
3. Codarri, L., G. Gyülvészi, V Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the efector phase of autoimmune neuroinfammation. Nat. Immunol. 12:560-567. http://dx.doi.org/10.1038/ni.2027
4. Corvol J.C., D. Pelletier, R.G. Henry, S.J. Caillier, J. Wang, D. Pappas, S. Casazza, D.T. Okuda, S.L. Hauser, J.R. Oksenberg, and S.E. Baranzini. 2008. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc. Natl. Acad. Sci. USA. 105:11839-11844. http://dx.doi.org/10.1073/pnas.0805065105
5. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F Safavi, G.X. Zhang, B.N. Dittel, and A. Rostami. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF Nat. Immunol. 12:568-575. http://dx.doi.org/10.1038/ni.2031
6. Fancy, S.P, S.E. Baranzini, C. Zhao, D.I. Yuk, K.A. Irvine, S. Kaing, N. Sanai, R.J. Franklin, and D.H. Rowitch. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23:1571-1585. http://dx.doi.org/10.1101/gad.1806309
7. Fantini, M.C., S. Dominitzki, A. Rizzo, M.F Neurath, and C. Becker. 2007. In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat. Protoc. 2:1789-1794. http://dx.doi.org/10.1038/nprot.2007.258
8. Hauser, S.L., and D.S. Goodin. 2012. Multiple Sclerosis and other demy-elinating diseases. In Harrison's principles of internal medicine. D.I. Longo, editor. McGraw-Hill, New York. 3395-3409.
9. Ho, K.J., N.L. Do, H.H. Otu, M.J. Dib, X. Ren, K. Enjyoji, S.C. Robson, E.F. Terwilliger, and S.J. Karp. 2010. Tob1 is a constitutively expressed repressor of liver regeneration. J. Exp. Med. 207:1197-1208. http://dx.doi.org/10.1084/jem.20092434
10. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; Sawcer, S., G. Hellenthal, M. Pirinen, C.C. Spencer, N.A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S.E. Hunt, et al. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476:214-219. http://dx.doi.org/10.1038/nature10251
11. Kennedy, K.A., T. Porter, V. Mehta, S.D. Ryan, F. Price, V. Peshdary, C. Karamboulas, J. Savage, T.A. Drysdale, S.C. Li, et al. 2009. Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biol. 7:67. http://dx.doi.org/10.1186/1741-7007-7-67
12. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 0995. B7-1 and B7-2 costimulatory molecules activate diferentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718. http://dx.doi.org/10.1016/0092-8674(95)90349-6
13. Lucchinetti, C., W Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47: 707-717. http://dx.doi.org/10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
14. Onuki, M., M.M. Ayers, C.C. Bernard, and J.M. Orian. 2001. Axonal degeneration is an early pathological feature in autoimmune-mediated de-myelination in mice. Microsc. Res. Tech. 52:731-739. http://dx.doi.org/10.1002/jemt.1057
15. Pedotti, R., J.J. DeVoss, S. Youssef, D. Mitchell, J. Wedemeyer, R. Madanat, H. Garren, P. Fontoura, M. Tsai, S.J. Galli, et al. 2003. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA. 100:1867-1872. http://dx.doi.org/10.1073/pnas.252777399
16. Peterson, J.W., L. Bö, S. Mörk, A. Chang, and B.D. Trapp. 2001. Transected neu-rites, apoptotic neurons, and reduced infammation in cortical multiple sclerosis lesions. Ann. Neurol. 50:389-400.http://dx.doi.org/10.1002/ana.1123
17. Raine, C.S., B. Cannella, S.L. Hauser, and C.P. Genain. 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specifc antibody mediation. Ann. Neurol. 46:144-160. http://dx.doi.org/10.1002/1531-8249(199908)46:2<144:: AID-ANA3>3.0.CO;2-K
18. Schulze-Topphof, U., A. Prat, T. Prozorovski, V. Sifrin, M. Paterka, J. Herz, I. Bendix, I. Ifergan, I. Schadock, M.A. Mori, et al. 2009. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat. Med. 15:788-793. http://dx.doi.org/10.1038/nm.1980
19. Sobel, R.A., and G.R.W. Moore. 2008. Demyelinating Diseases. In Greenfeld's neuropathology. J.G. Greenfeld, S. Love, D.N. Louis, and D. Ellison, editors. Hodder Arnold, London. 1513-1608.
20. Stüve, O., S. Youssef, M.S. Weber, S. Nessler, H.C. von Büdingen, B. Hemmer, T. Prod'homme, R.A. Sobel, L. Steinman, and S.S. Zamvil. 2006. Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. J. Clin. Invest. 116:1037-1044. http://dx.doi.org/10.1172/JCI25805
21. Trapp, B.D., J. Peterson, R.M. Ransohof, R. Rudick, S. Mörk, and L. Bö. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-285. http://dx.doi.org/10.1056/NEJM199801293380502
22. Tzachanis, D., G.J. Freeman, N. Hirano, A.A. van Puijenbroek, M.W. Delfs, A. Berezovskaya, L.M. Nadler, and V.A. Boussiotis. 2001. To b is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2:1174-1182. http://dx.doi.org/10.1038/ni730
23. Tzachanis, D., L. Li, E.M. Lafuente, A. Berezovskaya, G.J. Freeman, and V.A. Boussiotis. 2007. Twisted gastrulation (Tsg) is regulated by To b and enhances TGF-beta signaling in activated T lymphocytes. Blood. 109:2944-2952.
24. Winkler, G.S. 2010. The mammalian anti-proliferative BTG/Tob protein family. J. Cell. Physiol. 222:66-72. http://dx.doi.org/10.1002/jcp.21919
25. Xiong, B., Y. Rui, M. Zhang, K. Shi, S. Jia, T. Tian, K. Yin, H. Huang, S. Lin, X. Zhao, et al. 2006. Tob1 controls dorsal development of zebrafsh embryos by antagonizing maternal beta-catenin transcriptional activity. Dev. Cell. 11:225-238. http://dx.doi.org/10.1016/j.devcel.2006.06.012
26. Yoshida, Y., S. Matsuda, and T. Yamamoto. 1997. Cloning and characterization of the mouse tob gene. Gene. 191:109-113. http://dx.doi.org/10.1016/S0378-1119(97)00049-8
27. Yoshida, Y., A. von Bubnof, N. Ikematsu, I.L. Blitz, J.K. Tsuzuku, E.H. Yoshida, H. Umemori, K. Miyazono, T. Yamamoto, and K.W. Cho. 2003a. To b proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech. Dev. 120:629-637. http://dx.doi.org/10.1016/S0925-4773(03)00020-0
28. Yoshida, Y., T. Nakamura, M. Komoda, H. Satoh, T. Suzuki, J.K. Tsuzuku, T. Miyasaka, E.H. Yoshida, H. Umemori, R.K. Kunisaki, et al. 2003b. Mice lacking a transcriptional corepressor To b are predisposed to cancer. Genes Dev. 17:1201-1206. http://dx.doi.org/10.1101/gad.1088003
29. Zamvil, S.S., and L. Steinman. 2003. Diverse targets for intervention during infammatory and neurodegenerative phases of multiple sclerosis. Neuron. 38:685-688. http://dx.doi.org/10.1016/S0896-6273(03)00326-X
30. Zipp, F., H.P. Hartung, J. Hillert, S. Schimrigk, C. Trebst, M. Stangel, C. Infante-Duarte, P. Jakobs, C. Wolf, R. Sandbrink, et al; CCR1 Antagonist Study Group. 2006. Blockade of chemokine signaling in patients with multiple sclerosis. Neurology. 67:1880-1883. http://dx.doi.org/10.1212/01.wnl.0000244420.68037.86